Ensol Biosciences Inc. (XKON:140610)
13,000
-110 (-0.84%)
At close: May 14, 2026
-44.33% (1Y)
| Market Cap | 176.10B -44.7% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 13.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,538 |
| Average Volume | 9,261 |
| Open | 13,110 |
| Previous Close | 13,110 |
| Day's Range | 12,400 - 13,400 |
| 52-Week Range | 10,350 - 38,800 |
| Beta | 0.68 |
| RSI | 35.05 |
| Earnings Date | n/a |